The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease - PubMed (original) (raw)
The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease
A Iwai et al. Brain Res. 1996.
Abstract
NACP, the precursor of non-A beta component of Alzheimer's disease (AD) amyloid (NAC), is a synaptic protein that could potentially be involved in AD. We studied, by dot-blot, NACP levels in the frontal cortex of AD cases staged according to severity of disease and correlated them with cognitive performance and neuropathological markers. Early AD cases showed one fold higher levels of NACP immunoreactivity (IR) compared to moderate and severe AD. Levels of NACP-IR were correlated with tangle counts (r = -0.305, P = 0.04) and Blessed score (r = -0.356, P = 0.01), but not with plaque counts (r = 0.132, P = 0.39). This study suggests that the abnormal accumulation of NACP during the early stages of AD might play an important role in the mechanisms of neurodegeneration and synaptic damage in AD.
Similar articles
- Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid.
Paik SR, Lee JH, Kim DH, Chang CS, Kim J. Paik SR, et al. Arch Biochem Biophys. 1997 Aug 15;344(2):325-34. doi: 10.1006/abbi.1997.0207. Arch Biochem Biophys. 1997. PMID: 9264546 - NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.
Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr. Weinreb PH, et al. Biochemistry. 1996 Oct 29;35(43):13709-15. doi: 10.1021/bi961799n. Biochemistry. 1996. PMID: 8901511 - NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Nakashima H, Yasuda M, Kitamura Y, Uéda K, Checler F, Kuroda S. Yokota O, et al. Acta Neuropathol. 2002 Dec;104(6):637-48. doi: 10.1007/s00401-002-0596-7. Epub 2002 Aug 14. Acta Neuropathol. 2002. PMID: 12410385 - Mechanisms of synaptic dysfunction in Alzheimer's disease.
Masliah E. Masliah E. Histol Histopathol. 1995 Apr;10(2):509-19. Histol Histopathol. 1995. PMID: 7599445 Review. - [Alzheimer's disease: lesions and their progression].
Duyckaerts C, Colle MA, Delatour B, Hauw JJ. Duyckaerts C, et al. Rev Neurol (Paris). 1999;155 Suppl 4:S17-27. Rev Neurol (Paris). 1999. PMID: 10637934 Review. French.
Cited by
- Role of synucleins in Alzheimer's disease.
Crews L, Tsigelny I, Hashimoto M, Masliah E. Crews L, et al. Neurotox Res. 2009 Oct;16(3):306-17. doi: 10.1007/s12640-009-9073-6. Epub 2009 Jun 24. Neurotox Res. 2009. PMID: 19551456 Free PMC article. - The Role of Alpha-Synuclein in Neurodevelopmental Diseases.
Bordbar S, Alijanzadeh D, Samieefar N, Khazeei Tabari MA, Pourbakhtyaran E, Rezaei N. Bordbar S, et al. Mol Neurobiol. 2025 Jan;62(1):962-972. doi: 10.1007/s12035-024-04305-2. Epub 2024 Jun 29. Mol Neurobiol. 2025. PMID: 38949729 Review. - α-synuclein in the pathophysiology of Alzheimer's disease.
Twohig D, Nielsen HM. Twohig D, et al. Mol Neurodegener. 2019 Jun 11;14(1):23. doi: 10.1186/s13024-019-0320-x. Mol Neurodegener. 2019. PMID: 31186026 Free PMC article. Review. - Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy.
Lin S, Leitão ADG, Fang S, Gu Y, Barber S, Gilliard-Telefoni R, Castro A, Sung K, Shen R, Florio JB, Mante ML, Ding J, Spencer B, Masliah E, Rissman RA, Wu C. Lin S, et al. Neurobiol Dis. 2023 Mar;178:106010. doi: 10.1016/j.nbd.2023.106010. Epub 2023 Jan 23. Neurobiol Dis. 2023. PMID: 36702318 Free PMC article. - Neuropathology of non-Alzheimer degenerative disorders.
Dickson DW. Dickson DW. Int J Clin Exp Pathol. 2009 Aug 25;3(1):1-23. Int J Clin Exp Pathol. 2009. PMID: 19918325 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical